期刊文献+

慢性肾脏病患者低分子肝素抗氧化作用的研究 被引量:5

The effect of low molecular weight heparin as an antioxidant in chronic kidney disease
下载PDF
导出
摘要 目的阐明在慢性肾脏病(chronic kidney disease,CKD)时低分子肝素是否具有抗氧化作用,为临床治疗提供理论依据。方法选取CKD3~5期住院患者40例,随机分为低分子肝素(low molecular weight heparin,LMWH)组(速碧林0.4ml/d皮下注射,连续10d)及还原型谷胱甘肽(reduced glutathione,GSH)组(泰特1.8g/d加入0.9%NaCl溶液静脉滴注,连续10d)。测定2组用药前后血浆氧化应激指标谷胱甘肽过氧化物酶(glutathione peroxidase,GSH-PX)、丙二醛(malondialdehyde,MDA)、晚期氧化蛋白产物(advanced oxidation protein products,AOPP),并观察药物不良反应。结果 LMWH及GSH治疗后血浆AOPP水平均显著降低(P<0.05),GSH组AOPP降低值显著高于LMWH组,分别为(4.89±0.66)ìmol/L和(2.86±0.82)ìmol/L,差异有统计学意义(P<0.05);LMWH及GSH治疗后GSH-PX活力均显著升高(P<0.05),LMWH组和GSH组GSH-PX升高值分别为(3.55±1.01)×104U/L和(4.77±1.78)×104U/L,差异无统计学意义(P>0.05);LMWH治疗前后MDA分别为(5.54±1.66)nmol/ml和(5.42±1.40)nmol/ml,差异无统计学意义(P>0.05),GSH治疗后MDA活力比治疗前显著降低,分别为(5.09±1.44)nmol/ml和(4.61±1.30)nmol/ml,差异有统计学意义(P<0.05)。两组药物治疗期间均未见明显不良事件。结论 LMWH可以改善CKD患者氧化应激状态,短期应用未见明显不良反应。与GSH相比,LMWH的抗氧化作用稍弱。 Objective To identify the anti-oxidative effect of low molecular weight heparin (LMWH) in chronic kidney disease (CKD). Method Forty CKD patients at stage 3-5 were randomly divided into two groups, glutathione (GSH) group (0.9% NaCl 250ml + Glutathione 1.8g/d, intravenous injection for 10 days) and LMWH group (Fraxiparine 0.4ml/d, subcutaneous injection for 10 days). Plasma malondialdehyde (MDA), advanced oxidation protein product (AOPP) and glutathione peroxidase activity (GSH-PX) were measured at the beginning and the end of glutathione or LMWH administration. Results Plasma AOPP decreased and plasma GSH-PX increased significantly after the treatment in both LMWH and GSH groups (P0.05). The decrease of plasma AOPP was more significant in GSH group than in LMWH group (2.86±0.82 vs. 4.89±0.66μmol/l, P0.05). After the treatment, plasma MDA did not change significantly in LMWH group, but decreased (5.09±1.44 vs. 4.61±1.30nmol/ml, P0.05) in GSH group. There were no apparent side effects in both groups. Conclusion LMWH ameliorates oxidative stress state without apparent side effects. The anti-oxidative effect of LMWH is slightly lower than that of GSH.
出处 《中国血液净化》 2011年第3期129-132,共4页 Chinese Journal of Blood Purification
基金 教育部国家重点学科211二期重大项目(07TC14007) 上海市科学技术委员会重大科技攻关项目(08dz1900602)
关键词 氧化应激 慢性肾脏病 低分子肝素 还原型谷胱甘肽 Oxidative stress Chronic kidney disease Low molecular weight heparin Reduced glutathione
  • 相关文献

参考文献15

  • 1Locatelli F,Canaud B,Eckardt KU,et al.Oxidative stress in end-stage renal disease:an emerging threat to patient outcome[J].Nephrol Dial Transplant,2003,18:1272-1280.
  • 2National Kidney Foundation.K/DOQl clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].Am J Kidney Dis,2002,39:51-266.
  • 3Witko Sarsat V,Friedlander M,Nguyen Khoa T,et al.Advanced oxidation protein products as novel mediators ofinflammation and monocyte activation in chronic renal failure[J].J lmmunol,1998,161:2524-2532.
  • 4Kelly GS.Clinical applications of N-acetylcysteine[J].Altern Med Rev,1998,3:114-127.
  • 5Stephens NG,Parsons A,Schofield PM,et al.Randomised controlled trial of vitamin E in patients with coronary disease:Cambridge Heart Antioxidant Study(CHAOS)[J].Lancet,1996,347:781-786.
  • 6Marchioli R,Schweiger C,Tavazzi L.Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin Eafter myocardial infarction:results of the GISSIPrevenzione trial.Gruppo Italiano per to Studio della Sopravvivenza nell'Tnfarto miocardico[J].Lancet,1999,354:447-455.
  • 7Yusuf S,Dagenais G,Pogue J,et al.Vitamin E supplementation and cardiovascular events in high-risk patients.The Heart Outcomes Prevention Evaluation Study Investigators[J].N Engl J Med,2000,342:154-160.
  • 8Lonn E,Yusuf S,Dzavik V,et al.Effects of ramipril and vitamin E on atherosclerosis:the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E(SECURE)[J].Circulation,2001,103:919-925.
  • 9MRC/BLIP Heart Protection Study of antioxidant vitamin supplementation in 20,536 high risk individuals:a randomised placebo-controlled trial[J].Lancet,2002,360:23-33.
  • 10Manning RD,Jr.,Tian N,Meng S.Oxidative stress and antioxidant treatment in hypertension and the associated renal damage[J]Am J Nephrol,2005,25:311-317.

二级参考文献15

  • 1季宪飞,黄亮江.细胞黏附分子与急性肺损伤[J].中国危重病急救医学,2004,16(7):444-446. 被引量:8
  • 2Ghosh S,May M J,Kopp E B.NF-kappa B and Rel proteins:evolutionarily conserved mediators of immune responses[J].Annu Rev Immunol,1998,16:225-260.
  • 3Boldt J,Papsdorf M,Piper S N,et al.Continuous heparinization and circulating adhesion molecules in the critically ill[J].Shock,1999,11:13-18.
  • 4Shackelford R E,Alford P B,Xue Y,et al.Aspirin inhibits tumor necrosis factor-alpha gene expression in murine tissue macrophages[J].Mol Pharmacol,1997,52:421-429.
  • 5Vallet B,Wiel E.Endothelial cell dysfunction and coagulation[J].Crit Care Med,2001,29 (7 Suppl):S36-S41.
  • 6Hack C E,Zeerleder S.The endothelium in sepsis:source of and a target for inflammation[J].Crit Care Med,2001,29 (7 Suppl):S21-S27.
  • 7Collins T,Read M A,Neish A S,et al.Transcriptional regulation of endothelial cell adhesion molecules:NF-kappa B and cytokine-inducible enhancers[J].FASEB J,1995,9:899-909.
  • 8Yamaguchi H,Ishii E,Tashiro K,et al.Role of umbilical vein endothelial cells in hematopoiesis[J].Leuk Lymphoma,1998,31:61-69.
  • 9Terada L S,Hybertson B M,Connelly K G,et al.XO increases neutrophil adherence to endothelial cells by a dual ICAM-1 and P-selectin-mediated mechanism[J].J Appl Physiol,1997,82:866-873.
  • 10Tanaka N,Murata A,Uda K,et al.Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model[J].Crit Care Med,1995,23:901-908.

共引文献22

同被引文献55

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部